Which is more predictive ovarian sensitivity marker if there is discordance between serum anti-Müllerian hormone levels and antral follicle count? A retrospective analysis

References

• Abbara A, Vuong LN, Ho VNA, Clarke SA, Jeffers L, Comninos AN, et al. 2018. Follicle size on day of trigger most likely to yield a mature oocyte. Frontiers in Endocrinology 9:193.
   PubMed Web of Science ®Google Scholar
• Alebic MŠ, Stojanovic N, Dewailly D. 2018. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues. Human Reproduction 33:1141–1148.
   PubMed Web of Science ®Google Scholar
• Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, et al. 2018. Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (FOI) index. Frontiers in Endocrinology 9:589.
   PubMed Web of Science ®Google Scholar
• Andersen AN, Witjes H, Gordon K, Mannaerts B. 2011. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Human Reproduction 26:3413–3423.
   PubMed Web of Science ®Google Scholar
• Arce J-C, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. 2013. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertility and Sterility 99:1644–1653.
   PubMed Web of Science ®Google Scholar
• Broekmans FJM, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F, et al. 2010. The antral follicle count: practical recommendations for better standardization. Fertility and Sterility 94:1044–1051.
   PubMed Web of Science ®Google Scholar
• Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. 2013. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Human Reproduction Update 19:26–36.
   PubMed Web of Science ®Google Scholar
• Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. 1998. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertility and Sterility 69:505–510.
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L, et al. 2011. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction 26:1616–1624.
   PubMed Web of Science ®Google Scholar
• Gallot V, Berwanger da Silva AL, Genro V, Grynberg M, Frydman N, Fanchin R, et al. 2012. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Human Reproduction 27:1066–1072.
   PubMed Web of Science ®Google Scholar
• Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R, et al. 2011. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Human Reproduction 26:671–677.
   PubMed Web of Science ®Google Scholar
• Haadsma ML, Bukman A, Groen H, Roeloffzen EMA, Groenewoud ER, Heineman MJ, et al. 2007. The number of small antral follicles (2–6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Human Reproduction 22:1925–1931.
   PubMed Web of Science ®Google Scholar
• Hassan A, Kotb M, AwadAllah A, Wahba A, Shehata N. 2017. Follicular output rate can predict clinical pregnancy in women with unexplained infertility undergoing IVF/ICSI: a prospective cohort study. Reproductive Biomedicine Online 34:598–604.
   PubMed Web of Science ®Google Scholar
• Heidar Z, Bakhtiyari M, Mirzamoradi M, Zadehmodarres S, Sarfjoo FS, Mansournia MA, et al. 2015. Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF. Journal of Endocrinological Investigation 38:1007–1015.
   PubMed Web of Science ®Google Scholar
• Hornstein MD. 2016. State of the ART: assisted reproductive technologies in the United States. Reproductive Sciences 23:1630–1633.
   PubMed Web of Science ®Google Scholar
• Hsu A, Arny M, Knee AB, Bell C, Cook E, Novak AL, et al. 2011. Antral follicle count in clinical practice: analyzing clinical relevance. Fertility and Sterility 95:474–479.
   PubMed Web of Science ®Google Scholar
• Humaidan P, Alviggi C, Fischer R, Esteves SC. 2016. The novel POSEIDON stratification of 'low prognosis patients in assisted reproductive technology' and its proposed marker of successful outcome. F1000Research 5:2911.
   PubMedGoogle Scholar
• Hvidman HW, Bentzen JG, Thuesen LL, Lauritsen MP, Forman JL, Loft A, et al. 2016. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility. Human Reproduction 31:1034–1045.
   PubMed Web of Science ®Google Scholar
• Li R, Gong F, Zhu Y, Fang W, Yang J, Liu J, et al. 2016. Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study. Reproductive Biomedicine Online 33:506–512.
   PubMed Web of Science ®Google Scholar
• Li HWR, Lee VCY, Lau EYL, Yeung WSB, Ho PC, Ng EHY, et al. 2014. Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study. PLOS One 9:e108493.
   PubMed Web of Science ®Google Scholar
• Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, et al. 2013. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. Journal of Assisted Reproduction and Genetics 30:657–665.
   PubMed Web of Science ®Google Scholar
• Oehninger S, Nelson SM, Verweij P, Stegmann BJ. 2015. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles. Reproductive Biology and Endocrinology 13:117.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C, et al. 2011. Efficacy of induced luteinizing hormone surge after "trigger" with gonadotropin-releasing hormone agonist. Fertility and Sterility 95:826–828.
   PubMed Web of Science ®Google Scholar
• The Eshre Guideline Group On Ovarian Stimulation, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. 2020. ESHRE guideline: ovarian stimulation for IVF/ICSI. Human Reproduction Open 2020:hoaa009.
   PubMedGoogle Scholar
• Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B. 2014. Predictive value of anti-Müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET. Archives of Gynecology and Obstetrics 290:1249–1253.
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JS, Von BA, Cranfield M, Groome NP, Visser JA, et al. 2004. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction 10:77–83.
   PubMed Web of Science ®Google Scholar
• Yang M, Hall J, Fan Z, Regouski M, Meng Q, Rutigliano HM, et al. 2016. Oocytes from small and large follicles exhibit similar development competence following goat cloning despite their differences in meiotic and cytoplasmic maturation. Theriogenology 86:2302–2311.
   PubMed Web of Science ®Google Scholar
• Zhang N, Hao C-F, Zhuang L-L, Liu X-Y, Gu HF, Liu S, et al. 2013. Prediction of IVF/ICSI outcome based on the follicular output rate. Reproductive Biomedicine Online 27:147–153.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu Y, Xue Q, Shang J, Yang X, Shan X, et al. 2019. Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization. Reproductive Biology and Endocrinology 17:51.
   PubMed Web of Science ®Google Scholar